Cycn investor relations
WebInstitutional investors control 48.45% of the outstanding shares in CYCN. This represents a greater percentage of ownership than at almost any other company in the … WebCYCN Earnings Date Earnings Per Share Estimated Reported Quarterly Earnings Surprise Amount Yearly Earnings Forecast Quarterly Earnings Forecast Change in Consensus …
Cycn investor relations
Did you know?
WebApr 6, 2024 · Of the 23 institutional investors that sold Cyclerion Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Vanguard Group Inc. ($0.47M), State Street Corp ($0.32M), Renaissance Technologies LLC ($0.32M), Northern Trust Corp ($0.19M), FMR LLC ($0.13M), New … WebCyclerion Therapeutics Inc (NASDAQ:CYCN) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position …
WebMar 2, 2024 · Learn about the executive team and board of directors at Cyclerion Therapeutics Inc Ordinary Shares (CYCN:XNAS) and review their bios and … WebApr 6, 2024 · Of the 23 institutional investors that sold Cyclerion Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of …
WebApr 6, 2024 · CYCN Stock Forecast, Price & News (Cyclerion Therapeutics) S&P 500 4,109.31 DOW 33,274.15 JP Morgan analyst: Oil to hit $380 per barrel (Ad) [BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad) JP Morgan analyst: Oil to hit $380 per barrel (Ad) JP Morgan analyst: Oil to hit $380 per barrel (Ad) WebJun 4, 2024 · CAMBRIDGE, Mass., June 04, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company on a …
WebThe latest price target for . Cyclerion Therapeutics (NASDAQ: CYCN) was reported by Truist Securities on October 20, 2024.The analyst firm set a price target for $14.00 expecting CYCN to rise to ...
WebJan 12, 2024 · CYCN - Cyclerion Therapeutics Inc Ordinary Shares Sustainability - NASDAQ Morningstar Cyclerion Therapeutics Inc Ordinary Shares CYCN Sustainability Morningstar Rating Rating as of Jan 12,... flowers in albert lea mnWebCyclerion Investor Relations Team: [email protected] Auditors: Ernst & Young 200 Clarendon Street Boston, MA 02116 617.266.2000 Transfer Agent: Computershare Investor Services PO Box 43006 Providence, RI 02940-3078 Within USA, US … flowers in a circle svgWebApr 3, 2024 · Cyclerion Investor Relations Phone: 857-327-8778 Email: [email protected] Rejuvenate Your Portfolio with Options! Bounce back from 2024 with Chris Capre's expert options trade ideas for an... flowers in a greenhouseWebView Cyclerion Therapeutics, Inc CYCN investment & stock information. Get the latest Cyclerion Therapeutics, Inc CYCN detailed stock quotes, stock data, Real-Time ECN, … flowers in a jar melbourneWebMar 15, 2024 · Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, … green bay wisconsin newspaperWebSummary Financials Analysis Earnings Investors. . . Key Ratios Income Statement Balance Sheet Cash Flow. All. Per Share Values. Growth Rates. ... CYCN 2024. CYCN 3-Yr Avg. Biotech. 1-Yr Avg. Asset ... green bay wisconsin newspaper sportsWebJan 12, 2024 · Review Cyclerion Therapeutics Inc Ordinary Shares (CYCN:XNAS) stock and the current sustainability and ESG risk rating to help with your investing decisions. flowers in a kettle